TRVI – trevi therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Trevi Therapeutics to Participate in Upcoming April Investor Conferences [Yahoo! Finance]
Trevi Therapeutics to Participate in Upcoming April Investor Conferences
Trevi Therapeutics, Inc. (NASDAQ: TRVI) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $20.00 price target on the stock, up previously from $11.00.
Trevi Therapeutics, Inc. (NASDAQ: TRVI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.50 price target on the stock.
Trevi Therapeutics, Inc. (NASDAQ: TRVI) had its price target lowered by analysts at Needham & Company LLC from $25.00 to $24.00. They now have a "buy" rating on the stock.
Form 4 Trevi Therapeutics, Inc. For: Mar 25 Filed by: SCIASCIA THOMAS
Form 4 Trevi Therapeutics, Inc. For: Mar 21 Filed by: GOOD JENNIFER L
Form 144 Trevi Therapeutics, Inc. Filed by: GOOD JENNIFER L
Form SCHEDULE 13D/A Trevi Therapeutics, Inc. Filed by: New Enterprise Associates 16, L.P.
Form S-8 Trevi Therapeutics, Inc.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.